CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K See Remarks sold 3% of stake
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-26 | SANDELL SCOTT D 10% owner | Sale | −1,648,908 | $3.12 | $5.1M | 2,730,334 |
| 2023-01-26 | SANDELL SCOTT D 10% owner | Sale | −1,351,092 | $3.12 | $4.2M | 2,237,196 |
| 2023-01-25 | SANDELL SCOTT D 10% owner | Sale | −358,371 | $3.26 | $1.2M | 4,379,242 |
| 2023-01-25 | SANDELL SCOTT D 10% owner | Sale | −293,645 | $3.26 | $958K | 3,588,288 |
| 2023-01-19 | Hahn Brian M. SVP Finance, CFO | Grant or award · Employee Stock Option (right to buy) | +246,300 | 246,300 | ||
| 2023-01-19 | Semerjian Harout Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +651,200 | 651,200 | ||
| 2023-01-19 | Rock Edwin Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +244,800 | 244,800 | ||
| 2023-01-05 | SANDELL SCOTT D 10% owner | Sale | −39,223 | $2.76 | $108K | 4,737,613 |
| 2023-01-05 | SANDELL SCOTT D 10% owner | Sale | −32,139 | $2.76 | $89K | 3,881,933 |
| 2023-01-04 | SANDELL SCOTT D 10% owner | Sale | −56,054 | $2.91 | $163K | 4,776,836 |
| 2023-01-04 | SANDELL SCOTT D 10% owner | Sale | −45,930 | $2.91 | $134K | 3,914,072 |
| 2023-01-03 | SANDELL SCOTT D 10% owner | Sale | −96,084 | $2.99 | $287K | 4,832,890 |
| 2023-01-03 | SANDELL SCOTT D 10% owner | Sale | −78,730 | $2.99 | $235K | 3,960,002 |
| 2022-12-30 | SANDELL SCOTT D 10% owner | Sale | −66,690 | $3.02 | $201K | 4,928,974 |
| 2022-12-30 | SANDELL SCOTT D 10% owner | Sale | −54,645 | $3.02 | $165K | 4,038,732 |
| 2022-12-22 | Rock Edwin Chief Medical Officer | Purchase | +110,000 | $2.25 | $248K | 310,000 |
| 2022-11-17 | JUNIUS DANIEL M Director | Purchase | +20,000 | $1.87 | $37K | 63,250 |
| 2022-11-15 | Rock Edwin Chief Medical Officer | Purchase | +100,000 | $1.66 | $166K | 200,000 |
| 2022-11-14 | Rock Edwin Chief Medical Officer | Purchase | +100,000 | $1.43 | $143K | 100,000 |
| 2022-11-11 | PEARSON TIMOTHY R Director | Purchase | +19,400 | $1.29 | $25K | 24,650 |
Page 7 of 16 · 305 trades